Skip to content

Comparative genomics and receptor signaling in MBL and CLL arising in siblings

Comparative genomics and receptor signaling in MBL and CLL arising in siblings - MBL - CLL

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON41246
Enrollment
232
Registered
2013-01-31
Start date
2015-02-16
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Monoclonal B-cell lymphocytosis white blood cells without clinical relevance

Interventions

None listed

Sponsors

Leids Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: diagnosis of CLL or a sibling with CLL

Exclusion criteria

Exclusion criteria: n.a.

Design outcomes

Primary

MeasureTime frame
1) Definition of genetic differences between MBL en CLL as detected by whole exome sequencing and SNP microarray analysis 2) Detection of antigen-independent BCR signaling in MBL en CLL.

Secondary

MeasureTime frame
-

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)